Medicure MCUJF Stock
Medicure Price Chart
Medicure MCUJF Financial and Trading Overview
| Medicure stock price | 0.8 USD |
| Previous Close | 0.8 USD |
| Open | 0.75 USD |
| Bid | 0.76 USD x 1500000 |
| Ask | 0.85 USD x 100000 |
| Day's Range | 0.75 - 0.75 USD |
| 52 Week Range | 0.71 - 0.97 USD |
| Volume | 2K USD |
| Avg. Volume | 247 USD |
| Market Cap | 8.96M USD |
| Beta (5Y Monthly) | 0.971 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.47 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MCUJF Valuation Measures
| Enterprise Value | 7.58M USD |
| Trailing P/E | N/A |
| Forward P/E | 1.2307693 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.2862382 |
| Price/Book (mrq) | 0.91216946 |
| Enterprise Value/Revenue | 0.242 |
| Enterprise Value/EBITDA | -1.553 |
Trading Information
Medicure Stock Price History
| Beta (5Y Monthly) | 0.971 |
| 52-Week Change | -6.97% |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 0.97 USD |
| 52 Week Low | 0.71 USD |
| 50-Day Moving Average | 0.82 USD |
| 200-Day Moving Average | 0.82 USD |
MCUJF Share Statistics
| Avg. Volume (3 month) | 247 USD |
| Avg. Daily Volume (10-Days) | 710 USD |
| Shares Outstanding | 10.44M |
| Float | 5.28M |
| Short Ratio | 1.77 |
| % Held by Insiders | 26.59% |
| % Held by Institutions | 23.09% |
| Shares Short | 15.06K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -21.74% |
| Operating Margin (ttm) | -4.61% |
| Gross Margin | 39.67% |
| EBITDA Margin | -15.58% |
Management Effectiveness
| Return on Assets (ttm) | -15.51% |
| Return on Equity (ttm) | -41.56% |
Income Statement
| Revenue (ttm) | 31.32M USD |
| Revenue Per Share (ttm) | 3 USD |
| Quarterly Revenue Growth (yoy) | 44.89% |
| Gross Profit (ttm) | 12.43M USD |
| EBITDA | -4882000 USD |
| Net Income Avi to Common (ttm) | -6809000 USD |
| Diluted EPS (ttm) | -0.47 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.54M USD |
| Total Cash Per Share (mrq) | 0.15 USD |
| Total Debt (mrq) | 803K USD |
| Total Debt/Equity (mrq) | 6.34 USD |
| Current Ratio (mrq) | 1.038 |
| Book Value Per Share (mrq) | 0.87703 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3041000 USD |
| Levered Free Cash Flow (ttm) | -987750 USD |
Profile of Medicure
| Country | United States |
| State | MB |
| City | Winnipeg |
| Address | 2-1250 Waverley Street |
| ZIP | R3T 6C6 |
| Phone | 204 487 7412 |
| Website | https://www.medicure.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order, and online pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.
Q&A For Medicure Stock
What is a current MCUJF stock price?
Medicure MCUJF stock price today per share is 0.8 USD.
How to purchase Medicure stock?
You can buy MCUJF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medicure?
The stock symbol or ticker of Medicure is MCUJF.
Which industry does the Medicure company belong to?
The Medicure industry is Drug Manufacturers - Specialty & Generic.
How many shares does Medicure have in circulation?
The max supply of Medicure shares is 11.21M.
What is Medicure Price to Earnings Ratio (PE Ratio)?
Medicure PE Ratio is now.
What was Medicure earnings per share over the trailing 12 months (TTM)?
Medicure EPS is -0.47 USD over the trailing 12 months.
Which sector does the Medicure company belong to?
The Medicure sector is Healthcare.